JP2017516772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516772A5 JP2017516772A5 JP2016568812A JP2016568812A JP2017516772A5 JP 2017516772 A5 JP2017516772 A5 JP 2017516772A5 JP 2016568812 A JP2016568812 A JP 2016568812A JP 2016568812 A JP2016568812 A JP 2016568812A JP 2017516772 A5 JP2017516772 A5 JP 2017516772A5
- Authority
- JP
- Japan
- Prior art keywords
- dodeca
- oxo
- triazatricyclo
- trifluoromethyl
- tetraen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14169757.3 | 2014-05-23 | ||
| EP14169757 | 2014-05-23 | ||
| PCT/EP2015/061468 WO2015177367A1 (en) | 2014-05-23 | 2015-05-22 | Novel compounds useful as s100-inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017516772A JP2017516772A (ja) | 2017-06-22 |
| JP2017516772A5 true JP2017516772A5 (cg-RX-API-DMAC7.html) | 2018-05-10 |
| JP6580074B2 JP6580074B2 (ja) | 2019-09-25 |
Family
ID=50774707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568812A Expired - Fee Related JP6580074B2 (ja) | 2014-05-23 | 2015-05-22 | Ｓ１００阻害薬として有用な新規化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9771372B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2991990B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6580074B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170005868A (cg-RX-API-DMAC7.html) |
| CN (1) | CN106414448B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015261775B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016024749A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2948436A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA030604B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2620751T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016014483A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015177367A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11858984B2 (en) | 2018-04-27 | 2024-01-02 | National University Corporation Okayama University | Anti-S100A8/A9 antibody and use thereof |
| US11197908B2 (en) | 2018-07-17 | 2021-12-14 | The Board Of Trustees Of The University Of Arkansas | Peptoids and methods for attenuating inflammatory response |
| US20230144545A1 (en) | 2019-10-30 | 2023-05-11 | National University Corporation Okayama University | Prophylactic and/or therapeutic agent for inflammatory pulmonary disease |
| WO2023209141A1 (en) | 2022-04-29 | 2023-11-02 | Westfälische Wilhelms-Universität Münster | Benzo[d]imidazo[1,2-a]imidazoles and their use in diagnosis |
| WO2025132458A1 (en) | 2023-12-18 | 2025-06-26 | Chiesi Farmaceutici S.P.A. | Pyridazinyl amino derivatives as alk5 inhibitors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248755B1 (en) | 1999-04-06 | 2001-06-19 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| AR029489A1 (es) | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
| EP1305308B1 (en) | 2000-07-26 | 2006-12-20 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| CA2440037C (en) * | 2001-03-05 | 2010-02-16 | Transtech Pharma, Inc. | Benzimidazole derivatives for modulating the rage receptor |
| GB0117506D0 (en) | 2001-07-18 | 2001-09-12 | Bayer Ag | Imidazopyridinones |
| SE0104331D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Novel compounds |
| CN101613321A (zh) * | 2002-03-05 | 2009-12-30 | 特兰斯泰克制药公司 | 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物 |
| US20060111416A1 (en) | 2004-11-24 | 2006-05-25 | Lane Charlotte A L | Octahydropyrrolo[3,4-C]pyrrole derivatives |
| CA2663856A1 (en) | 2006-09-28 | 2008-04-10 | Exelixis, Inc. | Jak-2 modulators and methods of use |
| AU2008231384B2 (en) | 2007-03-23 | 2011-09-15 | Amgen Inc. | Heterocyclic compounds and their use |
| EP1986009A1 (en) * | 2007-04-26 | 2008-10-29 | Active Biotech AB | Screening method |
| AU2008266154A1 (en) | 2007-06-13 | 2008-12-24 | Claxosmithkltne Llc | Farnesoid X receptor agonists |
| SG189803A1 (en) * | 2008-01-22 | 2013-05-31 | Takeda Pharmaceutical | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| TW201004941A (en) | 2008-07-16 | 2010-02-01 | Wyeth Corp | Alpha7 nicotinic acetylcholine receptor inhibitors |
| MX2011009213A (es) | 2009-03-02 | 2011-12-14 | Sirtris Pharmaceuticals Inc | Quinolinas 8-sustituidas y analogos relacionados como moduladores de sirtuina. |
| WO2013067260A1 (en) | 2011-11-03 | 2013-05-10 | Genentech, Inc. | Bicyclic piperazine compounds |
| GB201321728D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
-
2015
- 2015-05-22 JP JP2016568812A patent/JP6580074B2/ja not_active Expired - Fee Related
- 2015-05-22 US US15/312,762 patent/US9771372B2/en not_active Expired - Fee Related
- 2015-05-22 MX MX2016014483A patent/MX2016014483A/es unknown
- 2015-05-22 WO PCT/EP2015/061468 patent/WO2015177367A1/en not_active Ceased
- 2015-05-22 ES ES15724640.6T patent/ES2620751T3/es active Active
- 2015-05-22 CA CA2948436A patent/CA2948436A1/en not_active Abandoned
- 2015-05-22 EP EP15724640.6A patent/EP2991990B1/en active Active
- 2015-05-22 CN CN201580026356.5A patent/CN106414448B/zh not_active Expired - Fee Related
- 2015-05-22 AU AU2015261775A patent/AU2015261775B2/en not_active Ceased
- 2015-05-22 EA EA201692405A patent/EA030604B1/ru not_active IP Right Cessation
- 2015-05-22 KR KR1020167035803A patent/KR20170005868A/ko not_active Withdrawn
- 2015-05-22 BR BR112016024749A patent/BR112016024749A2/pt not_active IP Right Cessation